2L94
Structure of the HIV-1 frameshift site RNA bound to a small molecule inhibitor of viral replication
Summary for 2L94
| Entry DOI | 10.2210/pdb2l94/pdb |
| Related | 1Z2J |
| NMR Information | BMRB: 17436 |
| Descriptor | RNA_(45-MER), N'-{(Z)-amino[4-(amino{[3-(dimethylammonio)propyl]iminio}methyl)phenyl]methylidene}-N,N-dimethylpropane-1,3-diaminium (2 entities in total) |
| Functional Keywords | rna, inhibitor, rna-inhibitor complex, rna/inhibitor |
| Total number of polymer chains | 1 |
| Total formula weight | 14856.23 |
| Authors | Marcheschi, R.J.,Tonelli, M.,Kumar, A.,Butcher, S.E. (deposition date: 2011-01-29, release date: 2011-06-15, Last modification date: 2024-05-15) |
| Primary citation | Marcheschi, R.J.,Tonelli, M.,Kumar, A.,Butcher, S.E. Structure of the HIV-1 Frameshift Site RNA Bound to a Small Molecule Inhibitor of Viral Replication. Acs Chem.Biol., 6:857-864, 2011 Cited by PubMed Abstract: Programmed -1 translational frameshifting is an essential event in the replication cycle of HIV. Frameshifting is required for expression of the viral Pol proteins, and drug-like molecules that target this process may inhibit HIV replication. A small molecule stimulator of HIV-1 frameshifting and inhibitor of viral replication, DB213 (RG501), was previously discovered from a high-throughput screen. However, the mechanistic basis for this compound's effects was unknown, and to date no structural information exists for small molecule effectors of frameshifting. Here, we investigate the binding of DB213 to the frameshift site RNA and have determined the structure of this complex by NMR. Binding of DB213 stabilizes the RNA and increases its melting temperature by 10 °C. The ligand binds to a primary site on the RNA stem-loop, although nonspecific interactions are also detected. The compound binds in the major groove and spans a distance of 9 base pairs. DB213 hydrogen bonds to phosphate groups on opposite sides of the major groove and alters the conformation of a conserved GGA bulge in the RNA. This study may provide a starting point for structure-based optimization of compounds targeting the HIV-1 frameshift site RNA. PubMed: 21648432DOI: 10.1021/cb200082d PDB entries with the same primary citation |
| Experimental method | SOLUTION NMR |
Structure validation
Download full validation report
